1. Home/
  2. Compounds/
  3. alisertib:navitoclax (2:1 mol/mol)

alisertib:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2alisertib:navitoclax (2:1 mol/mol)
PharmacoGx alisertib:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to alisertib:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ZNF783 CTRPv2 pan-cancer AAC 0.16 6e-06
mRNA ZNF776 CTRPv2 pan-cancer AAC 0.13 0.0003
mRNA ZNF775 CTRPv2 pan-cancer AAC 0.21 4e-08
mRNA ZNF77 CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA ZNF766 CTRPv2 pan-cancer AAC 0.24 1e-10
mRNA ZNF765 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA ZNF737 CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA ZNF736 CTRPv2 pan-cancer AAC 0.12 0.002
mRNA ZNF730 CTRPv2 pan-cancer AAC 0.13 0.0004
mRNA ZNF724 CTRPv2 pan-cancer AAC 0.13 0.0004
Download CSV